Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Infliximab

Neutropenia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Fitzpatrick T, et al. Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network. The Lancet Child and Adolescent Health 7: 648-656, No. 9, Sep 2023. Available from: URL: 10.1016/S2352-4642(23)00136-0 Fitzpatrick T, et al. Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network. The Lancet Child and Adolescent Health 7: 648-656, No. 9, Sep 2023. Available from: URL: 10.1016/S2352-4642(23)00136-0
Metadaten
Titel
Infliximab
Neutropenia
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56299-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Cladribine

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Bevacizumab